(13-092) Evaluating the Impact of Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Reinitiation versus Discontinuation Post Hospitalization with Acute Kidney Injury on Patient Outcomes

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: University of Tennessee Medical Center
Residency Program Type: PGY1 & PGY2 Combined (PGY1 Pharmacy & PGY2 Pharmacotherapy)
Residency Program Location: Tennessee

Co-Author(s): Shaunta Chamberlin, Luke Hentrich, William Dabbs, Thaddeus McGiness

Primary Author(s)

Leslie A. Phillips, PharmD

Pharmacist Resident
University of Tennessee Medical Center